Skip to NavigationSkip to content

Cedra appoints Anthony Busa

Published on: 14/05/10

Phase I clinical trial specialist Cedra Corp division has appointed Anthony Busa as its new permanent chief executive, replacing acting chief executive Thomas Wardle.

Wardle also serves as Cedra's chief operating officer and stepped into the chief executive role after company founder David Garcia stepped down earlier this year.

Busa has over 34 years of experience in management positions including senior level management, regional and national sales and product development within the pharmaceutical and medical device industries.

“Anthony is an experienced, high caliber professional. He has a thorough understanding of how this business and industry functions,” said Wardle. “He will be a great asset to our team in terms of growth and management.”

Busa previously held senior management positions at McClintic Busa Group, dgd Research, Esoterix, Medsites and Covance.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches